Filing Flows › Bioventus (BVS) › Gross margin
Bioventus (BVS) gross margin by quarter
Bioventus' gross margin was 68.2% in Q3 2026 (third quarter 2026), -0.8 pts from Q2 2026. Over the last 6 quarters it ranged from 68.0% (Q3 2025) to 69.1% (Q2 2025).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 68.2% | -0.8 pts | +0.2 pts |
| Q2 2026 | 69.0% | +0.3 pts | -0.2 pts |
| Q1 2026 | 68.7% | -0.2 pts | — |
| Q4 2025 | 68.9% | +0.9 pts | — |
| Q3 2025 | 68.0% | -1.2 pts | — |
| Q2 2025 | 69.1% | — | — |
Q3 2026 at a glance
Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bioventus' gross margin?
Bioventus' gross margin was 68.2% in Q3 2026 (third quarter 2026), -0.8 pts from Q2 2026.
How has Bioventus' gross margin changed?
Over the last 6 quarters it ranged from 68.0% (Q3 2025) to 69.1% (Q2 2025).